Diagnostic and Prognostic Performances Over 9 Years of a Selective Screening Strategy for Gestational Diabetes Mellitus in a Cohort of 18,775 Subjects
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We aimed to evaluate a selective screening strategy for gestational diabetes mellitus (GDM) based on the presence of risk factors: BMI ≥25 kg/m2, age ≥35 years, family history of diabetes, personal history of GDM, or birth of a child with macrosomia. RESEARCH DESIGN AND METHODS: Of 20,630 deliveries between 2002 and 2010, we selected 18,775 deliveries in women with no known diabetes and for whom all risk factors were known. GDM was universally screened and defined as fasting plasma glucose level ≥5.3 mmol/L and/or 2-h postload (75 g) glucose level ≥7.8 mmol/L. RESULTS: The prevalence of at least one risk factor has increased since 2002 (P < 0.001) from 51.7 to 61.5%, with no change in the GDM prevalence (mean 14.4%, intention to screen). At least one risk factor was present in 58.5% of women who represented 65.3% of all those with GDM. The presence of risk factors was significantly associated with GDM (odds ratio 1.4 [95% CI 1.3–1.5], P < 0.001) and with GDM-related events (preeclampsia/large for gestational age/dystocia) (P < 0.001) with the following incidences: no GDM/no risk factor 8.8%, no GDM/risk factor 11.1%, GDM/no risk factor 16.7%, and GDM/risk factor 18.2%. CONCLUSIONS: The presence of risk factors increased during the last decade. This condition is predictive of GDM and GDM-related events. However, a selective screening would lead to missing one-third of the women with GDM who, even without risk factors, had more events than women without GDM. Therefore, these data stand against the present selective screening currently proposed in the French guidelines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
Torloni, M. R., Betrán, A. P., Horta, B. L., Nakamura, M. U., Atallah, A. N., Moron, A. F., & Valente, O. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2008.00541.x · Cited by 739
Gestational diabetes: The consequences of not treating
Langer, O., Yogev, Y., Most, O., & Xenakis, E. M. J. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.11.039 · Cited by 677 · cited 1×
“For example, in women with GDM and BMI ,25 kg/m(2), the incidences of macrosomia and shoulder dystocia were reported to be similar regardless of whether GDM was known and treated (25).”
BackgroundHAPO Study Cooperative Research Group (2010) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2009.02486.x · Cited by 395 · cited 1×
“In the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study, higher BMI was associated with more preeclampsia, macrosomia, cesarean section, and shoulder dystocia (28).”
BackgroundPercentage of Gestational Diabetes Mellitus Attributable to Overweight and Obesity
Kim, S. Y., England, L., Wilson, H. G., Bish, C., Satten, G. A., & Dietz, P. (2010) · American Journal of Public Health · doi:10.2105/ajph.2009.172890 · Cited by 302 · cited 1×
“It is considered that nearly half the cases of GDMmight be a consequence of overweight or obesity (20).”
BackgroundGriffin, M. E., Coffey, M., Johnson, H., Scanlon, P., Foley, M., Stronge, J., O’Meara, N. M., & Firth, R. G. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00214.x · Cited by 185 · cited 1×
“Finally, a prospective study showed a better prognosis associated with universal than with selective screening, but an earlier screening in the universal strategy was confounding (27).”
Background
Cited by
Wang, H., Li, N., Chivese, T., Werfalli, M., Sun, H., Yuen, L., Hoegfeldt, C. A., Elise Powe, C., Immanuel, J., Karuranga, S., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109050 · Cited by 1,260
Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis
Ye, W., Luo, C., Huang, J., Li, C., Liu, Z., & Liu, F. (2022) · BMJ · doi:10.1136/bmj-2021-067946 · Cited by 1,073
A Clinical Update on Gestational Diabetes Mellitus
Sweeting, A., Wong, J., Murphy, H. R., & Ross, G. P. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac003 · Cited by 928
Baz, B., Riveline, J.-P., & Gautier, J.-F. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-0378 · Cited by 260
Muche, A. A., Olayemi, O. O., & Gete, Y. K. (2019) · Archives of Public Health · doi:10.1186/s13690-019-0362-0 · Cited by 128
“Selective screening strategy misses up to 45% of mothers with GDM [58, 59].”
BackgroundRisk factor screening for gestational diabetes mellitus based on the 2013 WHO criteria
Benhalima, K., Van Crombrugge, P., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., De Block, C., et al. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0117 · Cited by 60
Selective rather than universal screening for gestational diabetes mellitus?
Miailhe, G., Kayem, G., Girard, G., Legardeur, H., & Mandelbrot, L. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.05.003 · Cited by 51
Gestational Diabetes Mellitus: Screening and Outcomes in Southern Italian Pregnant Women
Capula, C., Chiefari, E., Vero, A., Arcidiacono, B., Iiritano, S., Puccio, L., Pullano, V., Foti, D. P., Brunetti, A., & Vero, R. (2013) · ISRN Endocrinology · doi:10.1155/2013/387495 · Cited by 43
Delivery outcomes of term pregnancy complicated by idiopathic polyhydramnios
Zeino, S., Carbillon, L., Pharisien, I., Tigaizin, A., Benchimol, M., Murtada, R., & Boujenah, J. (2017) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2017.02.014 · Cited by 30
Self-citationNwali, S. A., Onoh, R. C., Dimejesi, I. B., Obi, V. O., Jombo, S. E., & Edenya, O. O. (2021) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-04168-8 · Cited by 18
“The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study has helped to publish the most recent diagnostic criteria by the International Association of Diabetes in Pregnancy Study Groups (IADPSG) where the same test is used for both screening and diagnosis[21, 25].”
BackgroundResultInfluentialAubry, E. M., Raio, L., & Oelhafen, S. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108830 · Cited by 17
Metadata
- Authors
- Cosson, E., Benbara, A., Pharisien, I., Nguyen, M. T., Revaux, A., Lormeau, B., Sandre-Banon, D., Assad, N., Pillegand, C., Valensi, P., & Carbillon, L.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2013-02-13
- Volume
- 36
- Issue
- 3
- Pages
- 598-603
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2161584722
- Cited by
- 85
- References
- 6
- FWCI
- 8.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.